Risk factors for postoperative cervical haematoma in patients undergoing thyroidectomy: a retrospective, multicenter, international analysis (REDHOT study).
bleeding
cervical haematoma
complications
risk factors
thyroid surgery
thyroidectomy
Journal
Frontiers in surgery
ISSN: 2296-875X
Titre abrégé: Front Surg
Pays: Switzerland
ID NLM: 101645127
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
08
2023
accepted:
15
09
2023
medline:
18
10
2023
pubmed:
18
10
2023
entrez:
18
10
2023
Statut:
epublish
Résumé
Postoperative cervical haematoma represents an infrequent but potentially life-threatening complication of thyroidectomy. Since this complication is uncommon, the assessment of risk factors associated with its development is challenging. The main aim of this study was to identify the risk factors for its occurrence. Patients undergoing thyroidectomy in seven high-volume thyroid surgery centers in Europe, between January 2020 and December 2022, were retrospectively analysed. Based on the onset of cervical haematoma, two groups were identified: Cervical Haematoma (CH) Group and No Cervical Haematoma (NoCH) Group. Univariate analysis was performed to compare these two groups. Moreover, employing multivariate analysis, all potential independent risk factors for the development of this complication were assessed. Eight thousand eight hundred and thirty-nine patients were enrolled: 8,561 were included in NoCH Group and 278 in CH Group. Surgical revision of haemostasis was performed in 70 (25.18%) patients. The overall incidence of postoperative cervical haematoma was 3.15% (0.79% for cervical haematomas requiring surgical revision of haemostasis, and 2.35% for those managed conservatively). The timing of onset of cervical haematomas requiring surgical revision of haemostasis was within six hours after the end of the operation in 52 (74.28%) patients. Readmission was necessary in 3 (1.08%) cases. At multivariate analysis, male sex ( Based on our findings, we believe that patients with the identified risk factors should be closely monitored in the postoperative period, particularly during the first six hours after the operation, and excluded from outpatient surgery.
Sections du résumé
Background
UNASSIGNED
Postoperative cervical haematoma represents an infrequent but potentially life-threatening complication of thyroidectomy. Since this complication is uncommon, the assessment of risk factors associated with its development is challenging. The main aim of this study was to identify the risk factors for its occurrence.
Methods
UNASSIGNED
Patients undergoing thyroidectomy in seven high-volume thyroid surgery centers in Europe, between January 2020 and December 2022, were retrospectively analysed. Based on the onset of cervical haematoma, two groups were identified: Cervical Haematoma (CH) Group and No Cervical Haematoma (NoCH) Group. Univariate analysis was performed to compare these two groups. Moreover, employing multivariate analysis, all potential independent risk factors for the development of this complication were assessed.
Results
UNASSIGNED
Eight thousand eight hundred and thirty-nine patients were enrolled: 8,561 were included in NoCH Group and 278 in CH Group. Surgical revision of haemostasis was performed in 70 (25.18%) patients. The overall incidence of postoperative cervical haematoma was 3.15% (0.79% for cervical haematomas requiring surgical revision of haemostasis, and 2.35% for those managed conservatively). The timing of onset of cervical haematomas requiring surgical revision of haemostasis was within six hours after the end of the operation in 52 (74.28%) patients. Readmission was necessary in 3 (1.08%) cases. At multivariate analysis, male sex (
Conclusions
UNASSIGNED
Based on our findings, we believe that patients with the identified risk factors should be closely monitored in the postoperative period, particularly during the first six hours after the operation, and excluded from outpatient surgery.
Identifiants
pubmed: 37850042
doi: 10.3389/fsurg.2023.1278696
pmc: PMC10577166
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1278696Investigateurs
Giacomo Anedda
(G)
Cristina Soddu
(C)
Francesco Casti
(F)
Miriam Biancu
(M)
Silvia Puddu
(S)
Selina Russo
(S)
Andrea De Palma
(A)
Francesco Pignatelli
(F)
Elisa Loguercio
(E)
Livia Palmieri
(L)
Giulia Salvi
(G)
Priscilla Francesca Procopio
(PF)
Eleonora Morelli
(E)
Dorin Serbusca
(D)
Alessio Biagio Filippo Giordano
(ABF)
Giulia Fiorenza
(G)
Sophie Leboulleux
(S)
Nathalie Massé
(N)
Informations de copyright
© 2023 Canu, Medas, Cappellacci, Rossi, Gjeloshi, Sessa, Pennestrì, Djafarrian, Mavromati, Kotsovolis, Pliakos, Di Filippo, Lazzari, Vaccaro, Izzo, Boi, Brazzarola, Feroci, Demarchi, Papavramidis, Materazzi, Raffaelli, Calò and REDHOT Study Collaborative Group.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Références
Langenbecks Arch Surg. 2008 Sep;393(5):667-73
pubmed: 18633639
Surgery. 2013 Dec;154(6):1283-89; discussion 1289-91
pubmed: 24206619
World J Surg. 2021 Feb;45(2):515-521
pubmed: 33128087
Medicine (Baltimore). 2016 Feb;95(7):e2812
pubmed: 26886632
J Laryngol Otol. 2016 Jan;130 Suppl 1:S20-5
pubmed: 26687739
Kaohsiung J Med Sci. 2006 Nov;22(11):554-9
pubmed: 17110344
Endocrine. 2014 Nov;47(2):537-42
pubmed: 24563161
Int J Clin Exp Med. 2014 Jul 15;7(7):1837-44
pubmed: 25126188
Surgery. 2001 Dec;130(6):914-20
pubmed: 11742317
Laryngoscope. 2017 Jun;127(6):1483-1490
pubmed: 27481173
Front Oncol. 2022 Jul 07;12:954759
pubmed: 35875142
Langenbecks Arch Surg. 2008 Sep;393(5):733-7
pubmed: 18597109
World J Surg. 2012 Oct;36(10):2497-502
pubmed: 22714575
Eur J Endocrinol. 2017 May;176(5):591-602
pubmed: 28179452
BMC Surg. 2019 Jul 24;19(1):98
pubmed: 31340806
Br J Surg. 2021 Jul 23;108(7):851-857
pubmed: 33608709
Updates Surg. 2023 Sep;75(6):1393-1417
pubmed: 37198359
Gland Surg. 2020 Jan;9(Suppl 1):S14-S17
pubmed: 32055494
World J Surg. 2014 Jun;38(6):1262-7
pubmed: 24381046
Updates Surg. 2021 Dec;73(6):2263-2273
pubmed: 34196952
Ann Surg Oncol. 2016 Sep;23(9):2874-82
pubmed: 27138383
Ann Ital Chir. 2010 Sep-Oct;81(5):343-7
pubmed: 21294387
Int Arch Otorhinolaryngol. 2021 Jul;25(3):e421-e427
pubmed: 34377179
Gland Surg. 2020 Jun;9(3):721-726
pubmed: 32775262
Gland Surg. 2017 Oct;6(5):510-515
pubmed: 29142842
Eur Arch Otorhinolaryngol. 2009 Dec;266(12):1945-52
pubmed: 19301027
J Visc Surg. 2023 Jun;160(3S):S110-S118
pubmed: 37208220
Head Neck. 2016 Feb;38(2):216-9
pubmed: 25225123
Front Endocrinol (Lausanne). 2021 Jun 02;12:699805
pubmed: 34149628